Tyra Biosciences, Inc.
Tyra Biosciences is dedicated to developing next-generation precision molecules to address key drivers of disease, with a focus on overcoming mechanisms of resistance in cancer. Their proprietary discovery platform, SNÅP, enables rapid and structural insights to design targeted therapies that provide deeper responses and overcome resistance. The company is actively engaged in clinical studies, including BEACH301 for children with achondroplasia, and has raised significant funding to advance its pipeline of therapies targeting acquired resistance in oncology.
Industries
Nr. of Employees
small (1-50)
Products
Clinical-stage therapy for achondroplasia (investigational)
An investigational therapy currently being advanced in a pediatric clinical study for children with achondroplasia.
Discovery platform outputs (lead candidates and structural datasets)
Lead small-molecule candidates and associated structural and assay datasets generated by the internal structure-guided discovery workflow to advance selective inhibitors toward the clinic.
Clinical-stage therapy for achondroplasia (investigational)
An investigational therapy currently being advanced in a pediatric clinical study for children with achondroplasia.
Discovery platform outputs (lead candidates and structural datasets)
Lead small-molecule candidates and associated structural and assay datasets generated by the internal structure-guided discovery workflow to advance selective inhibitors toward the clinic.
Services
Structure-guided discovery platform (internal)
In-house discovery platform that combines rapid crystallography, prioritized assays, and iterative medicinal chemistry to accelerate small-molecule lead optimization.
Structure-guided discovery platform (internal)
In-house discovery platform that combines rapid crystallography, prioritized assays, and iterative medicinal chemistry to accelerate small-molecule lead optimization.
Expertise Areas
- Structure-based drug discovery
- Medicinal chemistry and computational design
- Protein crystallography and structural biology
- Assay development and in vivo pharmacology
Key Technologies
- Protein crystallography
- Structure-based drug design
- Computational chemistry
- Medicinal chemistry